Last $2.95 USD
Change Today +0.36 / 13.90%
Volume 7.7M
ATHX On Other Exchanges
As of 8:10 PM 03/2/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Gil Van Bokkelen Ph.D.

Co-Founder, Chairman and Chief Executive Officer, Athersys, Inc.
AgeTotal Calculated CompensationThis person is connected to 121 board members in 2 different organizations across 1 different industries.

See Board Relationships
As of Fiscal Year 2013


Dr. Gil Van Bokkelen, Ph.D. serves as an Investment Advisor to Early Stage Partners, a venture capital fund based in Ohio. Dr. Van Bokkelen co-founded Athersys, Inc. in October 1995 and has been its Chief Executive Officer since 1995. He served as the President at Athersys, Inc. until May 2006. He also played a fundamental role in developing the SMC technology. He has been the Chairman at Athersys, Inc. since August 2000 and has been its Director since 1995. He has been ...

Read Full Background

Corporate Headquarters*

3201 Carnegie Avenue
Cleveland, Ohio 44115

United States

Phone: 216-431-9900
Fax: 216-361-9495

Board Members Memberships*

Co-Founder, Chairman and Chief Executive Officer


Stanford University
University of California Berkeley

Other Affiliations*

Annual Compensation*

Total Annual Compensation$568,800

Stock Options*

Restricted Stock Awards$1,188,518
All Other Compensation$12,620
Exercisable Options760,625
Unexercisable Options161,875
Total Number of Options922,500

Total Compensation*

Total Annual Cash Compensation$581,420
Total Short Term Compensation$568,800
Other Long Term Compensation$1,201,138
Total Calculated Compensation$2,034,488
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ATHX:US $2.95 USD +0.36


Marc H. Hedrick M.D.Chief Executive Officer, President and Director
Cytori Therapeutics, Inc.
Martin M. McGlynn Chief Executive Officer, President, Director, Member of Strategic Transactions Committee, Chief Executive Officer of StemCells California Inc and President of StemCells California Inc
StemCells Inc.
David J. Mazzo B.A (Hons), B.Sc. (Hons.), M.Sc., Ph.D.Chief Executive Officer and Director
Neostem, Inc.
Paul K. Wotton Ph.D.Chief Executive Officer, President, Director and Member of Pricing Committee
Ocata Therapeutics, Inc.
Zami Aberman Executive Chairman and Chief Executive Officer
Pluristem Therapeutics, Inc.
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ATHERSYS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at